Mixed Reality for Parkinson's (NCT06459154)
Improve walking with mixed reality
- Trial ID
- NCT06459154
- Official Title
- The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease. Randomized Control Trial
- Goal
- Improve walking with mixed reality
- Phase
- NA
- Status
- UNKNOWN
- Sponsor
- University of Nicosia
- Study Type
- INTERVENTIONAL
- Enrollment
- 15 participants
- Conditions
- Parkinson Disease
- Interventions
- Mixed Reality, Traditional Physiotherapy
Summary For Families
The goal is to see whether using mixed reality exercises can boost quality of life for people with Parkinson's, especially by improving gait, balance, and everyday movement compared with standard physiotherapy. Mixed reality overlays virtual cues on the real world to guide movements, give real-time visual and audio feedback, and make walking and balance exercises more engaging and repetitive, while the comparison arm receives traditional physiotherapy. They're looking for people who can walk independently, have normal thinking ability, and are Greek native speakers, and they exclude those with other neurological disease, uncontrolled heart problems, recent musculoskeletal surgery, use of a walking aid, or significant vision loss; one phase accepts adults 18 and older and a later phase focuses on ages 60 and up. The trial is small, about 15 participants, run by the University of Nicosia.
Locations
- University of Nicosia, Nicosia, Engomi, Cyprus
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Mixed Reality. The goal is to see whether using mixed reality exercises can boost quality of life for people with Parkinson's, especially by improving gait, balance, and everyday movement compared with standard physiotherapy. Mixed reality overlays virtual cues on the real world to guide movements, give real-time visual and audio feedback, and make walking and balance exercises more engaging and repetitive, while the comparison arm receives traditional physiotherapy. They're looking for people who can walk independently, have normal thinking ability, and are Greek native speakers, and they exclude those with other neurological disease, uncontrolled heart problems, recent musculoskeletal surgery, use of a walking aid, or significant vision loss; one phase accepts adults 18 and older and a later phase focuses on ages 60 and up. The trial is small, about 15 participants, run by the University of Nicosia.
- Who can participate?
- Participants must be between 60 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 6 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has 3 groups, and 1 is a placebo group. Because assignment is random, you have about a 1 in 3 chance (roughly 33%) of being in the placebo group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.